Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

Figure][1] Jason S. Lewis, PhD Professor Jason S. Lewis holds the Emily Tow Chair at Memorial Sloan Kettering (MSK) in New York. He serves as deputy director of the Sloan Kettering Institute, ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

Radiopharmaceuticals represent a promising new frontier in cancer therapy. In the United States, cancer is the second leading cause of death. There is an urgent need to develop new therapies to meet ...

Journal of Nuclear Medicine February 2026, jnumed.123.266357; DOI: https://doi.org/10.2967/jnumed.123.266357 ...

SPECT myocardial perfusion imaging (MPI) is frequently used to evaluate patients for the presence of obstructive coronary artery disease (CAD) (1). Abnormalities of regional perfusion are used to ...

Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...

Simultaneous PET/MRI has shown potential for the comprehensive assessment of myocardial health from a single examination. Furthermore, MRI-derived respiratory motion information, when incorporated ...

Nectin cell adhesion molecule 4 (Nectin-4) is an emerging biomarker for cancer diagnosis and therapy. We developed a Nectin-4–targeted 68Ga-DOTA-Sar10-Nectin-4 (68Ga-FZ-NR-1) PET/CT radiotracer for ...

Fibrosing lung diseases affect over 160,000 individuals in the United States alone and can carry a prognosis that is worse than many cancers. Antifibrotic treatments modify only the rate of fibrosis ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251856; ...

Journal of Nuclear Medicine January 2025, jnumed.124.269268; DOI: https://doi.org/10.2967/jnumed.124.269268 The only research study on humans (3), using a tumor ...